Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Genus lifts FY profit outlook after 'strong' start, shares jump

(Sharecast News) - Genus shares shot higher on Wednesday after the animal genetics firm said FY26 adjusted pre-tax profit was set to be "modestly ahead" of the £80.5m midpoint of current market expectations after a strong start to the year. In an update for the four months to the end of October, Genus said trading in PIC (porcine genetics) remained strong, with every region achieving royalty revenue and adjusted operating profit growth.

The division performed particularly well in China, with strong royalty revenue growth being a key driver.

However, adjusted operating profit in ABS - the bovine genetics segment - has been slightly lower than expected due to phasing. Genus said it expects a step-up in performance in the second half.

Chief executive Jorgen Kokke said: "Genus has made a strong start to the year with PIC continuing to demonstrate its robust growth model.

"ABS profit performance has been slightly lower than expected but we expect stronger performance in the second half. We look forward to the rest of the year with confidence."

At 1345 GMT, the shares were up 8.2% at 2,570p.

House broker Panmure Liberum, which rates the stock at 'buy' with a 3,500p price target, said: "We've upgraded our PBT forecast by just under 5% to £84.2m but left our FY27E and beyond forecasts largely unchanged, preferring to remain cautious at this stage.

"Furthermore, the fact that Genus is willing to upgrade expectations this earlier in the year suggests that there may be more to come."

Share this article

Related Sharecast Articles

Nuveen's price for Schroders 'too cheap', says Panmure Liberum
(Sharecast News) - Panmure Liberum said on Thursday that US investment manager Nuveen's 612p a share takeover offer for Schroders is "too cheap" and "only a touch ahead of where we might have been pitching a new target price in an independent world".
Magnum Ice Cream results fail to impress as operating profit slides
(Sharecast News) - Shares in Magnum Ice Cream tumbled on Thursday as its first full-year results since the recent demerger from Unilever failed to impress.
THG strikes deal with Greencore to sell protein-enriched convenience foods
(Sharecast News) - THG is to target the booming obesity jab market through a strategic partnership with convenience food producer Greencore Group, it confirmed on Thursday.
RBC Capital Markets lowers target price on Barratt Redrow
(Sharecast News) - Analysts at RBC Capital Markets lowered their target price on property developer Barratt Redrow from 450p to 425p on Thursday as it updated its estimates to account for the firm's interim results.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.